DexCom Management
Management criteria checks 4/4
DexCom's CEO is Kevin Sayer, appointed in Jun 2011, has a tenure of 13.5 years. total yearly compensation is $15.71M, comprised of 7% salary and 93% bonuses, including company stock and options. directly owns 0.045% of the company’s shares, worth $13.95M. The average tenure of the management team and the board of directors is 3.9 years and 8.9 years respectively.
Key information
Kevin Sayer
Chief executive officer
US$15.7m
Total compensation
| CEO salary percentage | 7.0% |
| CEO tenure | 13.5yrs |
| CEO ownership | 0.04% |
| Management average tenure | 3.9yrs |
| Board average tenure | 8.9yrs |
Recent management updates
Recent updates
DexCom: Brighter 2025 From Stelo Ramp
Dec 10Is It Too Late To Consider Buying DexCom, Inc. (NASDAQ:DXCM)?
Dec 05
Are Investors Undervaluing DexCom, Inc. (NASDAQ:DXCM) By 44%?
Nov 08DexCom Growing Into Its Valuation, But Still No Bargain
Oct 25DexCom, Inc.'s (NASDAQ:DXCM) Price In Tune With Earnings
Oct 21DexCom Q3 Preview: Walking On Eggshells With Its Channel Relationships
Oct 16These 4 Measures Indicate That DexCom (NASDAQ:DXCM) Is Using Debt Safely
Sep 30DexCom: Investors Discounting Long CGM Growth Runway
Sep 19We Like These Underlying Return On Capital Trends At DexCom (NASDAQ:DXCM)
Sep 16DexCom Q2 Earnings: Traditional Market Overreaction
Aug 07Is Now The Time To Look At Buying DexCom, Inc. (NASDAQ:DXCM)?
Jul 26DexCom Q2: Surprising Earnings Miss With Hints Of Competitive Pressures
Jul 26Why Investors Shouldn't Be Surprised By DexCom, Inc.'s (NASDAQ:DXCM) P/E
Jul 12DexCom's ADA Conference Takeaways: Stelo, CGM Tailwinds Still Intact
Jul 03DexCom (NASDAQ:DXCM) Seems To Use Debt Rather Sparingly
Jun 28Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)
Jun 03Dexcom: Positive Catalysts Ahead To Support Growth
May 13If EPS Growth Is Important To You, DexCom (NASDAQ:DXCM) Presents An Opportunity
May 07DexCom: Attractive Discount After Strong Earnings Results
May 06Returns At DexCom (NASDAQ:DXCM) Are On The Way Up
Apr 25Why We're Not Concerned About DexCom, Inc.'s (NASDAQ:DXCM) Share Price
Apr 12DexCom Is Pricey For A Reason - Its Growth Story Reflects That
Apr 11Is DexCom (NASDAQ:DXCM) Using Too Much Debt?
Mar 29Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?
Mar 04DexCom: A Wealth Compounder In Healthcare
Feb 14DexCom: Stelo Stellar Outlook
Jan 17DexCom (NASDAQ:DXCM) Is Experiencing Growth In Returns On Capital
Jan 15DexCom, Inc. (NASDAQ:DXCM) Not Lagging Industry On Growth Or Pricing
Jan 01CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$681m |
| Jun 30 2024 | n/a | n/a | US$667m |
| Mar 31 2024 | n/a | n/a | US$639m |
| Dec 31 2023 | US$16m | US$1m | US$542m |
| Sep 30 2023 | n/a | n/a | US$377m |
| Jun 30 2023 | n/a | n/a | US$358m |
| Mar 31 2023 | n/a | n/a | US$293m |
| Dec 31 2022 | US$15m | US$953k | US$341m |
| Sep 30 2022 | n/a | n/a | US$244m |
| Jun 30 2022 | n/a | n/a | US$230m |
| Mar 31 2022 | n/a | n/a | US$258m |
| Dec 31 2021 | US$12m | US$900k | US$217m |
| Sep 30 2021 | n/a | n/a | US$577m |
| Jun 30 2021 | n/a | n/a | US$562m |
| Mar 31 2021 | n/a | n/a | US$530m |
| Dec 31 2020 | US$14m | US$800k | US$550m |
| Sep 30 2020 | n/a | n/a | US$231m |
| Jun 30 2020 | n/a | n/a | US$205m |
| Mar 31 2020 | n/a | n/a | US$148m |
| Dec 31 2019 | US$10m | US$691k | US$101m |
| Sep 30 2019 | n/a | n/a | -US$171m |
| Jun 30 2019 | n/a | n/a | -US$170m |
| Mar 31 2019 | n/a | n/a | -US$130m |
| Dec 31 2018 | US$10m | US$601k | -US$127m |
| Sep 30 2018 | n/a | n/a | US$43m |
| Jun 30 2018 | n/a | n/a | -US$5m |
| Mar 31 2018 | n/a | n/a | -US$33m |
| Dec 31 2017 | US$8m | US$546k | -US$50m |
Compensation vs Market: Kevin's total compensation ($USD15.71M) is about average for companies of similar size in the US market ($USD12.88M).
Compensation vs Earnings: Kevin's compensation has been consistent with company performance over the past year.
CEO
Kevin Sayer (66 yo)
13.5yrs
Tenure
US$15,712,244
Compensation
Mr. Kevin Ronald Sayer has been Executive Chairman of DexCom, Inc. since July 30, 2018. Mr. Sayer has been the Chief Executive Officer of DexCom, Inc. since January 5, 2015 and as its President since June...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 13.5yrs | US$15.71m | 0.045% $ 13.9m | |
| Executive VP | 4.8yrs | US$4.25m | 0.0083% $ 2.6m | |
| Executive VP & COO | 2.3yrs | US$4.94m | 0.066% $ 20.8m | |
| Executive VP & Chief Legal Officer | 2.9yrs | US$4.34m | 0.0014% $ 428.3k | |
| Executive VP & CTO | 2.2yrs | US$4.05m | 0.0014% $ 428.3k | |
| Director of Corporate Affairs & Head of Investor Relations | no data | no data | no data | |
| Executive Vice President of Strategy | 3.8yrs | no data | no data | |
| Executive Vice President of Marketing | less than a year | no data | no data | |
| Executive VP & Chief Human Resources Officer | 4.3yrs | no data | 0.0070% $ 2.2m | |
| Executive Vice President of Global Business Services | 7.9yrs | US$2.92m | no data | |
| Executive Vice President of Global Operations | 4.1yrs | no data | 0.0020% $ 622.1k | |
| Senior Director of Global Medical Science & Education | no data | no data | no data |
3.9yrs
Average Tenure
49yo
Average Age
Experienced Management: DXCM's management team is considered experienced (3.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 17.1yrs | US$15.71m | 0.045% $ 13.9m | |
| Lead Independent Director | 10.1yrs | US$393.51k | 0.014% $ 4.5m | |
| Independent Director | 11.1yrs | US$343.40k | 0.014% $ 4.5m | |
| Independent Director | 15.4yrs | US$346.49k | 0.097% $ 30.3m | |
| Independent Director | 15.1yrs | US$362.21k | 0.0095% $ 3.0m | |
| Independent Director | 5.3yrs | US$346.49k | 0.0053% $ 1.7m | |
| Independent Director | 4.2yrs | US$343.40k | 0.0040% $ 1.2m | |
| Independent Director | 4.3yrs | US$345.90k | 0.0039% $ 1.2m | |
| Independent Director | 7.8yrs | US$345.90k | 0.010% $ 3.1m | |
| Independent Director | 1.3yrs | US$404.72k | 0% $ 0 |
8.9yrs
Average Tenure
63yo
Average Age
Experienced Board: DXCM's board of directors are considered experienced (8.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:14 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
DexCom, Inc. is covered by 63 analysts. 24 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| James Francis Mainwaring | Atlantic Equities LLP |
| Anand Vankawala | Avondale Partners |
| null null | Baird |